Section of Hematology/Oncology, Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3A 1R9, Canada.
CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.
Curr Oncol. 2020 Dec 31;28(1):233-251. doi: 10.3390/curroncol28010026.
COVID-19 has spread rapidly, requiring health delivery systems to undertake dramatic transformations. To evaluate these system changes, we undertook one of the first Canadian health delivery system reviews and the first Canadian cancer centre evaluation of pandemic system modifications.
Questionnaires were distributed to the Canadian Association of Provincial Cancer Agencies (CAPCA) members in order to assess changes to cancer centre services and patient management. Documentation relating to COVID-19 from the CAPCA electronic space was accessed, and all publicly available cancer centre documentation related to COVID-19 was reviewed.
Seven provinces completed the questionnaire and had documentation available from the CAPCA electronic space. All screening programs across Canada were suspended. In most provinces surveyed, ≥50% of outpatient appointments were occurring virtually, with <25% using video platforms. Generally, the impact on diagnostic imaging and new patient referrals correlated with the impact of COVID-19. Most provinces had a reduction in operating room availability, with chemotherapy and radiation treatments continuing. Public health modification, including personal protective equipment and screening staff, varied across the country.
Canadian cancer centres underwent a rapid and aggressive transformation of services in response to COVID-19, with many similarities and differences across provinces. In part, this response was facilitated by communication under a national association, which in Canada remains unique to cancer. This response may serve to inform changes in other jurisdictions or disease states now and in future waves of the pandemic, as well as a record of changes for future health services and patient outcome research.
COVID-19 迅速传播,要求医疗服务系统进行重大变革。为了评估这些系统变化,我们进行了加拿大首个医疗服务系统评估之一,也是加拿大首个癌症中心对大流行系统修改的评估。
向加拿大省级癌症机构协会 (CAPCA) 的成员分发了调查问卷,以评估癌症中心服务和患者管理的变化。访问了 CAPCA 电子空间中与 COVID-19 相关的文档,并审查了所有与 COVID-19 相关的公开可用的癌症中心文档。
七个省份完成了问卷,并且 CAPCA 电子空间中有文档可用。加拿大所有的筛查项目都暂停了。在接受调查的大多数省份中,超过 50%的门诊预约是通过虚拟方式进行的,只有不到 25%的人使用视频平台。一般来说,诊断成像和新患者转诊的影响与 COVID-19 的影响相关。大多数省份的手术室可用性减少,化疗和放射治疗仍在继续。包括个人防护设备和筛查人员在内的公共卫生调整因国家而异。
加拿大癌症中心针对 COVID-19 迅速采取了积极的服务转型措施,各省之间存在许多相似之处和差异。在某种程度上,这种反应得益于在国家协会下进行的沟通,这在加拿大仍然是癌症特有的。这种反应可能有助于为现在和未来的大流行浪潮中的其他司法管辖区或疾病状态的变化提供信息,以及为未来的卫生服务和患者结果研究记录变化。